Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
110.17
+1.43 (1.32%)
At close: Jan 9, 2026, 4:00 PM EST
110.77
+0.60 (0.54%)
After-hours: Jan 9, 2026, 7:58 PM EST
Guardant Health Market Cap
Guardant Health has a market cap or net worth of $14.19 billion as of January 9, 2026. Its market cap has increased by 270.11% in one year.
Market Cap
14.19B
Enterprise Value
14.94B
1-Year Change
270.11%
Ranking
Category
Stock Price
$110.17
Market Cap Chart
Since October 4, 2018, Guardant Health's market cap has increased from $2.69B to $14.19B, an increase of 427.56%. That is a compound annual growth rate of 25.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 14.19B | 7.86% |
| Dec 31, 2025 | 13.16B | 248.64% |
| Dec 31, 2024 | 3.77B | 14.96% |
| Dec 29, 2023 | 3.28B | 17.84% |
| Dec 30, 2022 | 2.79B | -72.60% |
| Dec 31, 2021 | 10.17B | -21.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |